On April 26, 2022, HCA Healthcare, Inc. announced that at its annual general meeting of shareholders held on April 21, 2022, the shareholder proposal regarding lobbying disclosure as described in the Company's 2022 proxy statement was not approved.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
333.5 USD | +0.55% | +1.42% | +23.22% |
04:29pm | Wells Fargo Raises Price Target on HCA Healthcare to $315 From $303, Maintains Equalweight Rating | MT |
02:32pm | Ondine Biomedical appoints new interim chief financial officer | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.22% | 87.73B | |
+1.01% | 99.96B | |
+10.42% | 29.33B | |
-3.88% | 18.21B | |
-3.46% | 14.51B | |
+19.69% | 12.22B | |
+31.78% | 12B | |
+0.17% | 11.94B | |
-12.00% | 11.63B | |
-32.28% | 11.56B |
- Stock
- Equities
- Stock HCA Healthcare, Inc. - Nyse
- News HCA Healthcare, Inc.
- Declaration of Voting Results by HCA Healthcare, Inc